Dupilumab Rapidly Reduces IgE and Eosinophil Values in Kimura Disease: Sustained Remission Achieved
Dupilumab showed rapid and sustained efficacy in KD, suggesting its potential as a disease-modifying and corticosteroidsparing treatment option. Further controlled studies are warranted to validate these findings.
Authors
- Wo Yao
- Minghui Jia (ORCID: https://orcid.org/0000-0001-9344-4767)
- Bo Yang (ORCID: https://orcid.org/0000-0002-3183-5567)
- Bing Wang (ORCID: https://orcid.org/0000-0003-4945-7725)
- Hui Wang (ORCID: https://orcid.org/0000-0003-2568-7200)
- Hao Yu (ORCID: https://orcid.org/0000-0002-9778-8855)
Institutions
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Journal of Investigational Allergology and Clinical Immunology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.18176/jiaci.1126
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00